Assiamira Ferrara to Thiazolidinediones
This is a "connection" page, showing publications Assiamira Ferrara has written about Thiazolidinediones.
Connection Strength
2.180
-
Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9.
Score: 0.515
-
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
Score: 0.500
-
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
Score: 0.459
-
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
Score: 0.371
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011 Apr; 34(4):916-22.
Score: 0.093
-
Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 Oct; 95(10):4560-5.
Score: 0.088
-
Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
Score: 0.078
-
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study: response to Delea et al. Diabetes Care. 2004 Mar; 27(3):850-1; author reply 852-3.
Score: 0.057
-
Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
Score: 0.018